Suppr超能文献

嗜酸性粒细胞增多症:继发性、克隆性和特发性。

Eosinophilia: secondary, clonal and idiopathic.

作者信息

Tefferi Ayalew, Patnaik Mrinal M, Pardanani Animesh

机构信息

Division of Hematology, Department of Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA.

出版信息

Br J Haematol. 2006 Jun;133(5):468-92. doi: 10.1111/j.1365-2141.2006.06038.x.

Abstract

Blood eosinophilia signifies either a cytokine-mediated reactive phenomenon (secondary) or an integral phenotype of an underlying haematological neoplasm (primary). Secondary eosinophilia is usually associated with parasitosis in Third World countries and allergic conditions in the West. Primary eosinophilia is operationally classified as being clonal or idiopathic, depending on the respective presence or absence of a molecular, cytogenetic or histological evidence for a myeloid malignancy. The current communication features a comprehensive clinical summary of both secondary and primary eosinophilic disorders with emphasis on recent developments in molecular pathogenesis and treatment.

摘要

血液嗜酸性粒细胞增多症意味着要么是一种细胞因子介导的反应性现象(继发性),要么是潜在血液系统肿瘤的一种固有表型(原发性)。在第三世界国家,继发性嗜酸性粒细胞增多症通常与寄生虫病有关,而在西方则与过敏状况有关。原发性嗜酸性粒细胞增多症根据是否存在髓系恶性肿瘤的分子、细胞遗传学或组织学证据,在操作上分为克隆性或特发性。本通讯全面总结了继发性和原发性嗜酸性粒细胞增多症疾病,重点是分子发病机制和治疗方面的最新进展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验